BICO Group AB (publ) (OTCMKTS:CLLKF) Stock Price Down 3.7% – What’s Next?

BICO Group AB (publ) (OTCMKTS:CLLKFGet Free Report)’s stock price dropped 3.7% during mid-day trading on Tuesday . The stock traded as low as C$1.52 and last traded at C$1.52. 300 shares were traded during trading, a decline of 97% from the average session volume of 9,650 shares. The stock had previously closed at C$1.58.

BICO Group AB (publ) Price Performance

The business has a 50-day moving average of C$1.96 and a 200 day moving average of C$2.03.

BICO Group AB (publ) Company Profile

(Get Free Report)

BICO Group AB (publ), formerly known as CELLINK AB, is a biotechnology company specializing in the development and commercialization of tools and solutions for life science research. The company’s core offerings include advanced 3D bioprinters, proprietary bioinks, microfluidic devices and cell analytics instruments. These technologies are designed to accelerate drug discovery, tissue engineering and personalized medicine by enabling researchers to create and analyze complex biological models in vitro.

In addition to its flagship bioprinting platforms, BICO provides a broad portfolio of consumables and software that support end-to-end workflows for cell culture and bioprocessing.

Further Reading

Receive News & Ratings for BICO Group AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BICO Group AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.